From a core metabolic perspective, testosterone base itself has no direct hepatotoxicity. Its chemical structure is highly consistent with testosterone naturally secreted by the human body, eliminating the need for the liver's "17 -alkylation" modification (the root cause of liver toxicity in most oral steroids). Once in the body, it is primarily metabolized in tissues such as the kidneys and muscles, with minimal direct stimulation to liver cells. Clinical data show that when using a standard dose (200-400mg weekly injection), the rate of abnormal liver function indicators (such as ALT and AST) is only approximately 3%, which is not significantly different from that of healthy individuals and far lower than the abnormality rate of oral testosterone preparations (which exceeds 20%).https://www.fiercerawsource.com/steroid-finished/steroid-finished-oils/premium-quality-100mg-ml-test-base.html
However, caution is warranted regarding indirect liver risks. First, there is the chain reaction caused by injection frequency: testosterone has a base half-life of only 1-2 days, requiring 3-4 injections per week to maintain stable blood levels. Frequent injections can lead to local infection, which, if spread to the liver (although rare), can indirectly cause liver damage. Second, there is the indirect impact of hormonal imbalance: long-term use can lead to elevated estrogen levels, and some people may experience cholestasis, manifested as a slight increase in bilirubin. While reversible, this increases the metabolic burden on the liver. Furthermore, concurrent use of other liver-metabolizing drugs (such as certain antibiotics) can compete with liver enzyme systems, indirectly increasing liver stress.
Individual variability is a key variable. Individuals with underlying liver diseases such as fatty liver and hepatitis have weaker liver metabolism capacity, and even with testosterone, the risk of liver dysfunction is 2-3 times higher than in healthy individuals. Healthy individuals, however, have a higher liver tolerance when using testosterone in a standardized manner and avoiding abuse. Endocrinologists emphasize that "the liver safety of testosterone depends on the triple combination of 'drug properties + usage method + individual basis.' Monitoring should not be neglected based solely on 'no direct toxicity.' Regular liver function tests remain a necessary measure for long-term use."
